Elicio Therapeutics: Collaboration with Moffitt Cancer Center to Study AMP-CD19 in Combination with CD19 CAR T cells – CBI
Homepage /  Press Release /  Elicio Therapeutics: Collaboration with Moffitt Cancer Center to Study AMP-CD19 in Combination with CD19 CAR T cells

Press Release

Elicio Therapeutics: Collaboration with Moffitt Cancer Center to Study AMP-CD19 in Combination with CD19 CAR T cells